| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  deepc Increasing diagnostic quality through the collaboration of medical professionals and AI. deepc is a pioneering company in the realm of Radiology AI, poised to democratize access to health at scale. At the heart of our mission is ourproduct deepcOS®, an unrivaled cloud-native Radiology AI platform. With a vendor-agnostic approach, deepcOS® boasts an expansive repository of cutting-edge AI applications. This groundbreaking platform empowers radiologists to seamlessly include AI insights into their clinical workflows, ushering in a new era of patient care excellence and elevated diagnostic precision. Visit our website now or simply email us at contact@deepc.ai Digital Health, Deep Learning, Machine … Type: | 1 | 1 | 1 | 75 |
 |  Jefferies Jefferies, the global investment banking firm serving clients for more than 60 years. Jefferies is a leading global, full-service investment banking and capital markets firm that provides advisory, sales and trading, research and wealth and asset management services. With more than 40 offices around the world, we offer insights and expertise to investors, companies and governments. More about our company can be found at www.jefferies.com. Investment Banking, Fixed Income, Equities, Research & Strategy, Wealth Management, and Financial Services Type: | 8 | 2 | 6 | 7,802 |
 | Jolt Capital Scaling responsible deeptech companies Jolt Capital SAS is a fully independent Private Equity firm authorized and regulated by AMF (Autorité des Marchés Financiers) that specialises in Technology, targeting investments into companies with revenues between €10m and €50m. Jolt Capital generates returns for its investors by enabling mid-sized technology-rich companies with strong fundamentals to execute their growth strategies, in sectors that offer good exit potential across software and hardware alike (cybersecurity, sensors, photonics, industrial processes, new energy systems, applied AI, robotics...) In providing growth capital to our portfolio companies, we support their scaling in new markets, new capacities and new acquisitions, … Type: | 100 | 8 | 97 | 35 |
 | Mission Therapeutics Mission Therapeutics is a private, drug discovery and development company focused on selectively targeting deubiquitylating enzymes to treat diseases of high unmet need. Mission has built a world-leading platform for the discovery and development of first-in-class, small-molecule drugs that selectively target deubiquitylating enzymes (DUBs) – an emerging, and hitherto intractable, drug class that is attracting significant commercial interest as the potential ‘Next Kinase Area’. Mission’s DUB platform is yielding a rich pipeline of novel therapeutics for the benefit of patients across therapeutic areas. Mission’s strategy is to create value by advancing its pipeline programmes through early clinical development, and preferentially … Type: | 6 | 2 | 5 | 37 |
 | AAVantgarde Bio Delivering the next generation gene therapies AAVantgarde is a clinical-stage, international biotechnology company (headquartered in Italy) that has developed two proprietary adeno-associated viral (AAV) vector platforms to address the DNA cargo capacity limitations of AAV vectors Gene Therapy, Ophthalmology, and Rare diseases Type: | 1 | 1 | 0 | 28 |
 | Micropep Technologies Micropep is an innovative plant biotechnology company developing the next generation of biological crop protection solutions based on the incredible potential of micropeptides; short natural peptide molecules that target and regulate plant genes and proteins. Type: | 16 | 10 | 6 | 52 |
 | Asabys Partners Investing in Life. Investing in Science. Investing in Future. Asabys Partners is a venture capital firm from Barcelona investing across the board in human healthcare. We are active in the health-tech and biopharma industries and aim to invest in Spain and abroad in highly innovative and transformative technologies. We are motivated by the idea of pushing the boundaries of science and medicine. We do this through the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry. We have an entrepreneurial spirit and seek to be involved in … Type: | 20 | 3 | 17 | 12 |
 | Seamless Therapeutics Seamless Therapeutics is overcoming the boundaries of gene editing by unlocking the full potential of recombinases. Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach to restore health in patients with severe conditions in a safe and precise manner. Our technology platform unlocks the reprogramming of recombinases, a highly versatile class of enzymes. We are applying our proprietary know-how to develop a pipeline of disease-modifying product candidates across a broad spectrum of indications to expand the therapeutic potential of gene editing. Type: | 1 | 1 | 0 | 29 |
 | MSInsight Unlocking the Power of Genomics: Advancing Cancer Care and Precision Medicine MSInsight, a French health-tech company, empowers the fight against cancer by revealing actionable information from the genome. We are committed to developing a portfolio of state-of-the-art diagnostic solutions for Microsatellite Instability (MSI) status. MSI has been shown to be an indicator of treatment response, especially for immune checkpoint inhibitors, and as an important pan-cancer biomarker. We aim to propose bioinformatic tools for delivering insights on microsatellite mutational variations using Next-Generation Sequencing (NGS) data. Our flagship product, MSIcare, will be available as a robust diagnostic, prognostic, and theranostic assistant for … Type: | 36 | 6 | 35 | 7 |
 | BrightHeart Advancing prenatal ultrasound screening with AI At BrightHeart, we believe every single fetal ultrasound screening exam should be performed with the highest level of accuracy, so each mother and baby receive the highest possible quality of care. Type: | 2 | 2 | 1 | 11 |
 | VITAL MEAT Sustainable, healthy and delicious cultivated meat 🌎🍴 VITAL MEAT is a cultivated meat start-up based out of Nantes, France 🇫🇷 Our mission is to reduce human impact on the environment by providing HEALTHY, DELICIOUS, ETHICAL and SUSTAINABLE meat to billions of people 🌎 Thanks to our scalable technology and a cost effective process, we are gearing up to commercialize our first chicken product 🐔! Type: | 14 | 4 | 11 | 12 |
 | HV Capital Backing those who dare HV Capital is one of the leading early-stage and growth investors in Europe. With nine fund generations in 23 years and €2.8 bn in managed assets, HV Capital is one of the continent's most active investors. The investment team has many years of experience in identifying European startups with great potential for success. In addition to international success stories like Zalando, Delivery Hero, Sumup, and Depop, innovation leaders such as Enpal, Flixbus, Sennder, and Isar Aerospace are also part of the portfolio. HV Capital has invested in around 225 internet and technology companies, supporting startups with … Type: | 62 | 27 | 37 | 116 |
 | Octopus Ventures For the people and ideas that will change the world. For the people and ideas that will change the world, because we believe you can build a better tomorrow by investing in it. We can back you at every stage of your journey, from ideas on a page through to IPO. Each year we deploy more than £200 million across five areas where we see maximum potential for impact: health, fintech, deep tech, consumer and B2B software. With many years of experience and expertise investing in each of these areas, our team can help our portfolio companies scale at speed. … Type: | 26 | 19 | 5 | 123 |
 | Federal Ministry for Economic Affairs and Climate Action The major trends of the 21st century, notably globalisation, digitisation, demographic change, recent developments within the EU, and climate change all represent major challenges for German business to tackle. If we are to successfully address these issues, we need to develop our social market economy into a social-ecological market economy. This is the over-arching task for the Federal Ministry for Economic Affairs and Climate Action. Wirtschaft, Digitalisierung, Handelspolitik, Mittelstandspolitik, Energiewende, Europa, Wirtschaftliche Entwicklung, Industriepolitik, Luft- und Raumfahrt, Erneuerbare Energien, Außenwirtschaftsförderung, Existenzgründung, Tourismuspolitik, Energieeffizienz, Maritime Wirtschaft, Netzausbau, and Industrie 4.0 Type: | 75 | 31 | 16 | 1,001 |
 | International Union of Crystallography Advancing crystallography and structural science through primary research publication and extensive outreach activities The IUCr is an International Scientific Union. Its objectives are to promote international cooperation in crystallography and to contribute to all aspects of crystallography, to promote international publication of crystallographic research, to facilitate standardization of methods, units, nomenclatures and symbols, and to form a focus for the relations of crystallography to other sciences. Publishing, Crystallography, Open Access, Science, journals, online communities, and databases Type: | 16 | 0 | 12 | 129 |
 | Innogest Capital Investors in companies that make the difference, partner of entrepreneurial visionaries We are investors in companies that make the difference. We trust in great entrepreneurs, we partner with hard-working visionaries. Innogest is a Venture Capital firm focused on seed and early stage ventures, with more than € 200 milion of capital under management. We have over 100 years of cumulative professional experience in the digital and the healthcare fields. Innogest invests in high potential companies through a direct share in their equity and pays special attention to market potential and size. Innogest leverages its extensive network of contacts, working alongside … Tags: H2020 Type: | 4 | 0 | 1 | 16 |
 | Atlas Venture We build breakthrough biotech companies with remarkable life science entrepreneurs. Atlas Venture is a leading biotech venture capital firm. With the goal of doing well by doing good, we have been building breakthrough biotech startups since 1993. We work side by side with exceptional scientists and entrepreneurs to translate high impact science into medicines for patients. Our seed-led venture creation strategy rigorously selects and focuses investment on the most compelling opportunities to build scalable businesses and realize value. Biotech and Venture Capital Type: | 6 | 2 | 4 | 137 |
 | Founders Future Founded by entrepreneurs for entrepreneurs, we invest financial and human capital in tech and digital startups. Founded by the serial European tech entrepreneur, Marc Ménasé, Founders Future is a venture studio, providing creativity, network, support and productive capital. We've built a investment platform dedicated to entrepreneurs and managed by entrepreneurs, bringing high value and an ambitious mindset. We aim to partner with outstanding personalities, to align stakeholder’s interest and to foster operational partnerships. Our mission is to become a sparring-partner and continuously try to impact the business on the product, go-to-market, business development and talent acquisition. We've hired top-notch operating … Type: | 69 | 29 | 55 | 20 |
 | IRDI Capital Investissement IRDI Capital Investissement is a trusted partner, investor of the innovation and the SME on the South West of France. Based in Toulouse, Montpellier and Bordeaux, the management company IRDI Capital Investissement support in capital the companies based in the South West at every stages of their development (initiation, risk capital, development capital / transmission) for an cumulative oustanding amount of 300 million of euros. Type: | 79 | 26 | 68 | 40 |
 | Académie des technologies [Automatic translation follows] For reasoned progress, chosen and shared Founded in 2000, the Academy of Technologies brings together 370 academics, including five Nobel Prize winners, all experts in their respective fields, and from very diverse backgrounds: the world of industrial and academic research, economists, sociologists, architects, doctors, etc. It analyzes the opportunities and risks related to new technologies, and is committed to improving the attractiveness of technological professions, particularly for young people and women. The Academy issues proposals and recommendations to public authorities, socio-economic actors and citizens for better use of technologies for the benefit of people, in accordance with … Type: | 66 | 13 | 70 | 84 |
 | SISTAFUND We are a new generation of venture capital funders backing exceptional female founders and gender-balanced teams We are a new generation of venture capital funders backing exceptional female founders and gender-balanced teams. SISTAFUND is a pan-European VC fund backing female founders and gender-balanced teams, building companies that challenge the status quo. With a target of €100 million, SISTAFUND will be deployed from pre-seed to Series A, mainly in France and Europe, with some investments in the U.S. SISTAFUND’s ambition is twofold: Drive the performance of backed companies, since start-ups founded or co-founded by women are 2.5 times more profitable investments … Type: | 58 | 12 | 56 | 7 |
 | LimFlow SA Providing minimally-invasive options for the treatment of end-stage chronic limb-threatening ischemia (CLTI) LimFlow SA, part of Inari Medical, Inc., is a leading provider of medical technology that provides new hope to patients suffering from the most severe form of peripheral artery disease, Chronic Limb-Threatening Ischemia (CLTI), and who are facing the prospect of amputation. LimFlow is revolutionizing healthcare by offering a breakthrough solution for end-stage CLTI patients when traditional treatments fall short. Using an innovative percutaneous procedure, the LimFlow System reinvents anatomy to restore blood flow to the ischemic foot, which aims to alleviate pain, foster wound healing, reduce amputations … Type: | 1 | 1 | 0 | 27 |
 | Inventiva Pharma A clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies. Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the areas of fibrosis, lysosomal storage disorders and oncology. Our research and development programs target indications with substantial unmet medical needs: NASH, MPS and oncology. Drug Discovery, Biotech, Oncology, Fibrosis, Lysosomal Storage Disorders, NASH, and SSc Type: | 1 | 1 | 0 | 111 |
 | Niryo Niryo is a French startup designing collaborative #robots for universities, engineering schools, R&D & training centers. Niryo is a French startup designing desktop collaborative #robots for universities, engineering schools, training centers and research centers. Its reality? Democratizing cobotics and allowing its accessibility, while promoting a new vision for industry tinted with reason, humanity, durability and resilience. To keep on materializing this ambition, a team of forty passionate develop cutting edge hardware and software. This way, professionals are free to automate, research and train without a hassle. Embeddable in a variety of ecosystems, Niryo's cobots promote the awareness of a world … Type: | 48 | 9 | 16 | 51 |
 | Invyo Europe's leading data platform for data-driven investors (Venture Capital / Private Equity / Family Office) Since 2018, INVYO has been the trusted partner for investors in private equity, venture capital and family offices. We are a reference platform in Europe, propelling investors towards a data and tech-driven investment model thanks to AI. Our sector expertise harnesses your data to boost your human and financial performance. - French publisher - More than 50 client funds - 16 data experts - 2 offices: Paris & Madrid - SaaS solutions Our mission : At INVYO, we unleash the potential of investment teams through … Type: | 71 | 4 | 71 | 21 |
 | Kiro Artificial intelligence serving clinical biology Kiro is a fast-moving startup developing solutions for better patient care, powered by artificial intelligence. We aim at improving everyone’s health by supporting patients and doctors with understandable and relevant information. We believe that medical biology is at the heart of healthcare. It contributes greatly to the diagnosis, treatment and prevention of diseases. Our mission is to foster the interactions between laboratories, health professionals and patients, to go beyond results in patient care thanks to new technologies and artificial intelligence. Since its inception, Kiro has worked in close partnership with clinical biologists, doctors and medical … Tags: FrenchTech2030 Type: | 33 | 11 | 22 | 57 |
 | Interaction Healthcare [Automatic translation follows] Your strategy deserves the best treatment 100% digital agency specializing in the health sector. Founded in 2008, Interaction Healthcare's expertise is based on 4 pillars: - digital strategy consulting; - web and social media solutions; - mobile solutions and new interfaces; - digital medical simulation and serious game. Interaction Healthcare designs and develops digital communication and e-learning tools for the pharmaceutical industry, university hospitals, simulation centers, learned societies, patient associations, health professionals and the general public. Recognized as an innovative company by the Oséo Excellence 2012 network and a partner of INRIa, a digital research laboratory, the … Type: | 42 | 5 | 40 | 12 |
 | Calm/Storm Entrepreneurship is a continuous storm Calm/Storm is an exclusive founder network and boutique venture capital firm. We focus on talents, not industries. We believe in lifelong learning & personal growth, empowering entrepreneurs with unique access to successful founders. We are a fund built by founders for founders. Type: | 18 | 5 | 17 | 37 |
 | Wellington Partners Wellington Partners is one of the most successful pan-European venture capital firms. With funds totalling over € 800 million, we have invested throughout Europe in companies that have the potential to become real market leaders for more than 15 years. We are committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically lead financing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, our own commitment can go as high as € 15 million. Providing funding is only one part of our business. After funding, the entrepreneurs … Type: | 4 | 4 | 0 | 36 |
 | Dieter von Holtzbrinck Ventures DvH Ventures | Investing early in Europe's most passionate founders. Dieter von Holtzbrinck Ventures (DvH Ventures) is one of Europe's leading early stage investors. As an entrepreneurial venture capitalist, DvH Ventures invests in emerging technology companies and builds successful investment clusters in areas such as Digital Health, Education, DeepTech or Climate Tech/ESG. Founded in 2014, partners Duc Quyen Tran, Peter Richarz and Fabian von Trotha manage several venture capital funds from their Cologne office. In addition to financial investments, DvH Ventures supports its portfolio companies with management expertise, in-depth industry knowledge and an international investor network. An exclusive media-for-equity programme … Type: | 28 | 6 | 18 | 10 |
 | Entreprises Occitanie [Automatic translation follows] The region's leading economic magazine. Founded in 1983, Entreprises Occitanie covers regional economic news by highlighting all sectors of activity. Designed by a team of professional journalists and published by Medef 31, this monthly is available in 10 issues, supplemented by the Top Economique Occitanie which lists more than 10,000 decision-makers in the region. Reports, portraits of entrepreneurs and the calendar of major events are regularly published on the web. aeronautics, agri-food, space, innovation, finance, employment / training, health, and building Type: | 58 | 4 | 57 | 6 |
 | MoonLake Immunotherapeutics (NASDAQ: MLTX) Creating next-level therapies for inflammatory skin and joint diseases with Nanobody® science MoonLake Immunotherapeutics AG is a clinical-stage biopharmaceutical company leveraging revolutionary Nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases. Immunotherapy, inflammatory skin & joint diseases, partnering, IL17A / F, #MLTX, #Nanobody, #HS, #PsA, and #IL17 | 3 | 1 | 2 | 79 |
 | Qorium Real Leather, Reinvented Leather is loved. Leather is luxury. Leather is everywhere. Unfortunately, making leather is also polluting, challenging and controversial. Qorium creates beautiful, premium, and authentic leather without compromise. Cutting-edge science empowers us to dramatically reduce the vast impacts of today’s leather industry without quality reductions. By removing the cow from leather production, Qorium’s material has minimal climate impacts, low water and chemical usage, no land use, and no animal impacts. Simply put, Qorium reinvents leather. Better product. Better planet. Biotechnology, Cell cultured leather, Leather, Cell grown Leather, Sustainable Leather, and Animal free Leather Type: | 1 | 0 | 1 | 18 |
 | Nuage Therapeutics We develop new selective and potent drugs for intrinsically disordered targets. Nuage Therapeutics is a spin-off from the Institute for Research in Biomedicine (IRB Barcelona) and ICREA. Nuage Therapeutics mission is to leverage biomolecular condensation and chemical biology to develop selective inhibitors of intrinsically disordered proteins involved in challenging indications representing unmet medical needs. Type: | 5 | 2 | 2 | 21 |
 | Noema Pharma Developing therapies to restore functioning in patients with orphan conditions of the brain and nervous system. Noema Pharma is a biotech company developing groundbreaking therapies to address the most disabling symptoms in orphan conditions of the brain and nervous system. Noema’s research and development is focused on understanding and meeting patient needs using our novel therapies. CNS | 1 | 1 | 0 | 30 |
 | Moorfields Eye Hospital, London Moorfields is one of the world’s leading eye hospitals, providing expertise in clinical care, research and teaching and education. Our main focus is the treatment and care of NHS patients with a wide range of eye problems, from common complaints to rare conditions, which require treatments not available anywhere else in the UK. We have over 30 locations in and around London, which enables us to provide expert treatment closer to patients’ homes. We are also a postgraduate teaching centre and a national centre for ophthalmic research involving, with the UCL Institute of Ophthalmology, the largest ophthalmic research programme in … Type: | 3 | 2 | 1 | 1,791 |
 | Latham & Watkins Latham & Watkins is a global law firm with more than 3,500 lawyers in its offices located in Asia, Europe, the Middle East and the United States. The firm has internationally recognized practices in a wide spectrum of transactional, litigation, corporate and regulatory areas. Our success is grounded in our devotion to the collaborative process, which reaches across global offices and practices and draws upon our deep subject matter expertise, an abiding commitment to teamwork and a powerful tradition of creative lawyering. Follow us on Twitter @lathamwatkins Join us on Facebook www.facebook.com/lathamwatkins Subscribe to us on YouTube http://youtube.com/lathamwatkinsglobal Content may … Type: | 9 | 4 | 5 | 7,633 |
 |  Enrupt Building companies of the future Transition is not enough. We require a radical change, we require a transformation to achieve tangible changes in our business and society centered on net zero objective by 2050. We are 25 years from 2050 and any asset or infrastructure invested today will still be in operation by 2050. We can’t dream of a better world. We need to create it by our actions today. We need to disrupt energy in us, our organisations and around us. energy, innovation, startups, decarbonisation, decentralisation, and digitalisation Type: | 7 | 0 | 7 | 1 |
 | Bien Commun Advisory [Automatic translation follows] The conviction that, in the "common good", the greatest good is first and foremost what is common to us. Bien Commun Advisory is a consulting firm specializing in communication strategy, economic information, public affairs and media relations. Founded by Antoine Boulay in 2019, it now has around fifteen employees and works for large companies, SMEs, start-ups, federations and players in the associative world. Type: | 35 | 1 | 29 | 13 |
 | DISCO Pharmaceuticals GmbH The surfaceome company. DISCO’s pioneering surfaceome mapping platform transforms the current approach of target discovery for large molecule R&D. The technology identifies proteins and protein communities across the entire cancer cell surface in a scalable manner, thus addressing the need for target candidates for both mono- and bi-specific antibodies. These insights enable the development of a multitude of cancer-selective therapies, with the potential to boost efficacy and reducing side effects for patients. Type: | 1 | 1 | 0 | 24 |
 | 2CFinance [Automatic translation follows] Independent financial consulting firm, specializing in Transaction Services and Part Time DAF Our mission: "Advise investors and managers to diagnose and improve the quality and performance of corporate financial departments". • Consulting firm, based in Paris 9th, Aix-en-Provence and Nantes. • Two professions: delegated operational financial management and financial consulting. • A team of 50 employees. • More than 500 missions conducted in Small and MidCap companies, respecting absolute discretion and confidentiality. • A portfolio of renowned entrepreneurs, managers and investment funds. • Long experience in supporting companies in different key phases of their development (start-up, growth, … | 50 | 11 | 44 | 102 |
 | mind Health [Automatic translation follows] The strategic information service dedicated to the digital transformation of the healthcare industries. mind Health is a B2B service offering dedicated to the transformation of the healthcare industries, innovation and the transformation of the value chain in the healthcare ecosystem. Offering information, monitoring and analysis, mind Health is aimed at all the players and sectors that make up this ecosystem: pharmaceutical and medical device industries, electronics, IT and telecoms, mutual insurance companies and insurance companies, public and private healthcare offerings, service providers, etc. Type: | 81 | 5 | 79 | 4 |
 | Pixium Vision S.A. Innovating at the frontier of neuroscience : brain machine interfacing the Eye and the Brain - from photons to neurons ! One must remember the notion that restoring some vision to those who have lost their sight is possible, has long been thought to be fanciful. However, we are in the Age of Neural Prostheses, Bioelectronics, and BMI. At frontier of neuroscience, interfacing the worlds of eye and the brain – “from Photons to Neurons”. Such is the breadth and depth of knowledge needed to build a world of bionic vision for those with vision loss. This is the mission … Type: | 7 | 5 | 1 | 26 |
 | Cardiologs AI Serving Cardiology Cardiologs is a medical technology company on a mission to democratize expert cardiac care through medical-grade artificial intelligence. Machine Learning, Big Data, MedTech, Cardiology, Artificial Intelligence, ECG analysis, Holter analysis, and SaaS Type: | 13 | 8 | 3 | 82 |
 | OrbiMed OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, through a range of private equity funds, public equity funds, and royalty/credit funds. OrbiMed seeks to be a capital provider of choice, providing tailored financing solutions and extensive global team resources to help build world-class healthcare companies. OrbiMed’s team of over 100 professionals is based in New York City, San Francisco, Shanghai, Hong Kong, Mumbai, Herzliya, and other key global markets. Biotechnology, Healthcare, Financial Services, Fund Management, and Investment Management Type: | 6 | 2 | 4 | 148 |
 | Longwood Fund Longwood creates and invests in science-based companies that develop novel solutions for important medical problems Longwood creates and invests in science-based companies that develop novel solutions for important medical problems. Healthcare and Biotech and entrepreneurialism Type: | 4 | 1 | 0 | 19 |
 | Gilde Healthcare Specialized healthcare investor in both Healthcare Venture & Growth as well as Healthcare Private Equity, managing €2.5B Gilde Healthcare is a specialized European healthcare investor managing two business lines: a lower mid-market buy-out fund and a venture & growth capital fund. Gilde Healthcare's lower mid-market buy-out fund invests in profitable European healthcare services companies with a focus on the Netherlands, Belgium and Germany. The portfolio consists of healthcare providers, suppliers of medical products and other service providers in the healthcare market. Gilde Healthcare's venture & growth capital fund invests in medtech, diagnostics, digital health and therapeutics. The portfolio companies are … Type: | 5 | 3 | 2 | 63 |
 | Amadeus Capital Partners We invest in people who create transformational technologies and sustainable businesses. Amadeus Capital Partners is a global technology investor. Since 1997, the firm has raised over $1bn for investment and used it to back more than 180 companies. With vast experience and a great network, Amadeus’ team of investors and entrepreneurs share a passion for the transformative power of technology. Pioneering businesses we’ve backed include cyber security vendor ForeScout (NASDAQ:FSCT); Graphcore, innovators in intelligent microprocessors; IVF genetic testing company, Igenomix; the first single-chip Bluetooth solution, CSR (acquired by Qualcomm); IndiaMART, the B2B online marketplace (NSE: INDIAMART) and speech recognition company … Type: | 38 | 10 | 20 | 47 |
 | Principles for Responsible Investment The UN-supported Principles for Responsible Investment, the world’s leading proponent of responsible investment. The Principles for Responsible Investment (PRI) is an investor initiative in partnership with UNEP FI and the UN Global Compact. Founded in 2006 and supported by the United Nations, the PRI has become the leading network for investors demonstrating their commitment to responsible ownership and long-term, sustainable returns. Pension funds, insurance companies, sovereign/development funds, investment managers and service providers make up the PRI network. Our goal is to grow investor interest in environmental, social and corporate governance issues (ESG), share best practice and support signatory needs in … Type: | 10 | 8 | 2 | 343 |
 | Le Monde [Automatic translation follows] The leading news, everywhere, all the time, by the editorial staff of Le Monde. LeMonde.fr has been on the Internet since December 19, 1995, 51 years to the day after the creation of the paper newspaper. The site and its mobile applications are among the most consulted in France to follow the news in real time (international, economic, political, social, ...) Leading news website in French. Journalism, Media, Online press, Written press, Internet, Video, and Ethics Type: | 288 | 207 | 76 | 2,754 |
 | La French Care [Automatic translation follows] The Health Actors Movement Our mission? To unite the Health ecosystem. La French Care is the Health Actors Movement, it is supported by Bpifrance and the association Acteurs de la French Care, which brings together private and public actors in the health sector in France. La French Care is at the service of the development of ecosystems and excellence in the service of the patient. The mission of La French Care: to promote and develop excellence in health in France. Type: | 32 | 17 | 15 | 7 |
 | La Course des Lumières [Automatic translation follows] Together, let's light up the night against the disease and for all the sick! Created in 2010, the Course des Lumières is a national awareness event around the fight against the disease. Since its creation, more than one million euros have been collected for the benefit of health organizations (foundations, hospitals, patient associations, etc.). Accessible to all, the event brings together more than 15,000 participants and 200 companies each year. Each participant, runner or walker, symbolically carries a luminous object to "light up the night against the disease and for all the sick". solidarity, sport, running, walking, … Type: | 6 | 5 | 1 | 1 |
 | Sustainability Consult Credible sustainability & bioeconomy communications. Led by Conscious Business Leader Kathryn Sheridan since 2008. Sustainability Consult is dedicated to raising Credibility and Visibility for organisations worldwide. We are the leading bioeconomy communications and PR agency, based in Brussels, operating internationally. A trusted partner and recognised source for the media, Sustainability Consult has a proven track record in brand building, corporate communications and PR. We offer a full service of high-level consultancy services, from PR to communications and online strategy, through to issues management and crisis communications, as well as events, reports and media monitoring. We tweet @SustConsult. Follow us on … Type: | 9 | 3 | 6 | 3 |
 | Enersens Enersens produces the best thermal barriers and additives to improve safety, energy efficiency and flame protection Enersens is a leading innovative company specializing in silica aerogel products. We develop and market high performance aerogel-based insulation materials. We aim to become the leader in these high performance materials to enable our customers and partners to achieve their own goals around global trends in energy efficiency, sustainability, electric mobility and clean energy. Our Skogar® products solve the thermal runaway problems of batteries for any type of electric vehicle or electric mobility. Their performance and finesse also make it possible to solve many … Type: | 34 | 5 | 32 | 7 |
 | HighLife Trans-septal Mitral Valve Replacement HighLife is a trans-catheter mitral valve replacement company committed to bringing the best minimally invasive technology to the patients. | 5 | 2 | 1 | 74 |
 | TISSIUM Biomorphic Programmable Polymers TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function. Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas. Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices. We have developed a fully … Tags: FrenchTech120 Type: | 14 | 9 | 5 | 122 |
 | Womed This is a women's world Womed is pioneering innovative, safe and effective treatments to free women from challenging uterine pathologies: infertility, uterine bleeding, endometriosis. Type: | 10 | 1 | 1 | 13 |
 | enginzyme Developing technologies to meet the sustainability goals of the future Our ambition is to play a key role in tackling climate change, by enabling green chemistry for every industry. We do this by creating the most general and efficient technology platform for chemical production that the world has ever seen. That’s a big claim, but we can stand behind it. By bio-upgrading the chemical industry with our cell-free biomanufacturing platform, we can produce the products that modern society relies on in a truly sustainable way. The technology platform utilises nature’s catalysts, enzymes, by combining the power of biology with the … Type: | 2 | 0 | 2 | 59 |
 | T. Rowe Price T. Rowe Price is a premiere global asset management organization, actively investing in opportunities to help people thrive in an evolving world. Headquartered in Baltimore, Maryland, we provide a broad range of investment solutions across equity, fixed income, and multi-asset capabilities for clients around the world—from individuals to advisors to institutions to retirement plan sponsors. Our active, independent investing approach has guided how we do business for more than 85 years. Our professionals have diverse perspectives, but are united behind a commitment to rigorous research. They collaborate to identify market risks and opportunities that can give clients sharper insights and … Type: | 2 | 1 | 1 | 8,987 |
 | The Carlyle Group Carlyle (NASDAQ: CG) is a global investment firm with deep industry expertise that deploys private capital across three business segments: Global Private Equity, Global Credit and Global Investment Solutions. With $435 billion of assets under management as of June 30, 2024, Carlyle’s purpose is to invest wisely and create value on behalf of its investors, portfolio companies and the communities in which we live and invest. Carlyle employs more than 2,200 people in 29 offices across four continents. Notices & Disclaimers: https://www.carlyle.com/notices-and-disclaimers AlpInvest Private Equity Investment Management, LLC (“APEIM”) is the investment advisor to Carlyle AlpInvest Private Equity Markets (CAPM) … Type: | 9 | 8 | 0 | 2,441 |
 | Linklaters Linklaters is a leading global law firm, supporting and investing in the future of our clients wherever they do business. We combine legal expertise with a collaborative and innovative approach to help clients navigate constantly evolving markets and regulatory environments, pursuing opportunities and managing risk worldwide. http://www.linklaters.com Attorney Advertising: Prior results do not guarantee a similar outcome Type: | 27 | 12 | 14 | 14 |
 | Umiami The next generation of plant-based meat. Tasty, Tender, and Sustainable whole-cuts. Umiami is a French foodtech that was founded in 2020 with the mission to reduce worldwide meat consumption and its impact on health, animals, and the environment. We are pioneers in the development of a patent-pending process for texturizing plant proteins called "umisation". With our umisation technology, we can recreate the meat and fish fillet experience without compromising on taste and texture. After opening our first pilot plant innovation center last year, Umiami will inaugurate its first large-scale production plant in October 2023. The 14,000m2 site is located in … Tags: FrenchTech120 FrenchTech2030 Type: | 38 | 20 | 24 | 104 |
 | Home Biosciences A new breed of biotech company A new breed of biotech company aiming to unlock scientific breakthrough by leveraging an asset-centric operating model Type: | 6 | 4 | 3 | 7 |
 | Marsh We help our clients and colleagues grow — and our communities thrive — by protecting and promoting Possibility. We help our clients and colleagues grow — and our communities thrive — by protecting and promoting Possibility. We seek better ways to manage risk and define more effective paths to the right outcome. We go beyond risk to rewards for our clients, our company, our colleagues, and the communities in which we serve. Marsh is the world’s leading insurance broker and risk advisor. With over 45,000 colleagues operating in 130 countries, Marsh serves commercial and individual clients with data-driven risk solutions … Type: | 13 | 10 | 3 | 12 |
 | Evonik Leading in specialty chemicals and beyond to make the world a better place. Evonik is one of the world’s leading specialty chemicals companies. While we don’t produce electric cars, aircraft, medications or 3D printers, Evonik is part and parcel of these and many other end products. That’s because we contribute the small things that make a big difference. We make electric car batteries perform better, aircraft greener, medications more effective and 3D printers more efficient. In short: We think beyond the bounds of chemistry to make the world a better place. Today and tomorrow. We are an international group with … Type: | 13 | 6 | 5 | 13,849 |
 | AlbionVC Backing visionary founders with long-term capital & scale-up expertise. Partners to B2B software & healthcare companies. AlbionVC supports visionary founders with long-term capital and scale-up expertise. Founded in 1996, today we are partners to UK early-stage software, healthcare and deeptech companies. AlbionVC manages c. $1 billion of venture funds, currently invested in over 50 companies. AlbionVC is the technology investment arm of Albion Capital Group LLP, which is authorised and regulated by the Financial Conduct Authority. Type: | 30 | 8 | 25 | 31 |
 | Cancer Campus [Automatic translation follows] Cancer Campus is a research and innovation park that is developing in Villejuif (Val-de-Marne) Cancer Campus is a research and innovation park that is developing in Villejuif (Val-de-Marne), around Gustave Roussy, the leading cancer center in Europe. Its goal is to bring together all the talents (health professionals, researchers, students, companies) and citizens concerned by the disease to become an international reference site in health and cancer innovation. In this context, we are developing 3 programs dedicated to promoting entrepreneurship in oncology: - the Oncoentrepreneur program: tailor-made training and support set up for start-up projects in biotech, … Type: | 5 | 1 | 3 | 3 |
 | F-Prime Capital We create and invest in healthcare and technology companies that impact lives all over the world. Our roots are in one of America’s great entrepreneurial success stories. Fidelity Investments was founded in 1946 and grew from a single mutual fund into one of the largest asset management firms in the world, with over $2 trillion in assets under management. For the last forty years, our venture capital group has had the privilege of backing other great entrepreneurs as they built ground-breaking companies in technology and life sciences, including Atari, MCI, ROLM Corp., Alibaba, Ironwood Pharmaceuticals, and Ultragenyx. Today our funds … Type: | 12 | 5 | 7 | 96 |
 | HLTH USA Boldly stepping into health's future 🦄 Be bold and join us at HLTH USA 2024 October 20-24. HLTH is the leading platform bringing together the entire health ecosystem, focused on health innovation and transformation. From unparalleled events with industry-leading speakers to inspirational digital content and mission-driven initiatives, HLTH creates a unique marketplace for the health community leading the dialogue and development of a better health ecosystem. Join us in transforming the next decade of health, together. Type: | 39 | 7 | 26 | 73 |
 | GENFIT Dedicated to improving the lives of patients with liver diseases characterized by high unmet medical needs. GENFIT is a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and severe liver diseases characterized by high unmet medical needs. GENFIT is a pioneer in liver disease research and development with a rich history and strong scientific heritage spanning more than two decades. Its capacity to develop high potential assets, from early-stages to late development and pre-commercialization stages, is illustrated through the successful 52-week readout of its Phase 3 trial (ELATIVE®) evaluating elafibranor in Primary Biliary Cholangitis (PBC). Today, … Type: | 7 | 3 | 5 | 183 |
 | Varenne Capital Partners Varenne Capital Partners is a Paris-based, process-driven, global investment manager whose purpose is to deliver superior long-term returns with the minimum necessary risk-taking. We strive to achieve this goal by employing proprietary research and combining complementary investment frameworks in a single strategy: Long Equity, Short Equity, Merger Arbitrage and Tail Risk Hedging. Our ‘brokers are not welcome’ policy means that we rely exclusively on our own internal research and base our analysis on facts and figures. All of our investment frameworks stem from years of research and development and as a result comprise original methodologies, formalized processes, dedicated teams of … Type: | 5 | 2 | 1 | 39 |
 | Mainstay Medical First and Only FDA Approved Restorative Therapy for Chronic Mechanical Low Back Pain Mainstay Medical, led by a team of dedicated scientists, executives, engineers, and clinical experts, brings to you ReActiv8®, the first and only FDA-approved restorative treatment for mechanical chronic low back pain. RESTORE Control RESTORE Function RESTORE Stability ReActiv8 LIFE The Company was incorporated in Dublin, Ireland and headquartered in San Diego, CA. It has subsidiaries operating in Ireland, the United States, Australia, Germany and the Netherlands. Type: | 1 | 0 | 1 | 136 |
 | Endpoints News The biopharma world is here Endpoints is the biopharma world's leading source for breaking news, smart analysis and exclusive access. We cover the intersection of science, money and power in the world's most innovative industry, and are a part of the Financial Times' FT Specialist group. Biotechnology, News, Drug Development, and Pharmaceuticals Type: | 20 | 4 | 19 | 62 |
 | The Francis Crick Institute We are a biomedical discovery institute breaking down barriers between disciplines. The Crick is a distinctive biomedical research institute. We’re committed to advancing, promoting, and sharing understanding of human health and disease. We do that by attracting talented and ambitious people from all disciplines and backgrounds and giving them the support and freedom they need to succeed. Inside the Crick, you’ll discover scientists working to stretch the very limits of what we know about how life works. Their research holds the key to answering fundamental questions about human health and disease. Our bold and innovative research projects bring together scientists … Type: | 11 | 4 | 6 | 1,706 |
 | EuropaBio - the European Association for Bioindustries Innovative biotechnology, benefiting people and planet. EuropaBio, the European Association for Bioindustries, promotes an innovative and dynamic European biotechnology industry. EuropaBio and its members are committed to the socially responsible use of biotechnology to improve quality of life, to prevent, diagnose, treat and cure diseases, to improve the quality and quantity of food and feedstuffs and to move towards a biobased and zero-waste economy. Type: | 21 | 7 | 18 | 32 |
 | Quest for health [Automatic translation follows] Healthcare accelerator in the heart of Europe. For biotech, medtech and digital health startups. Quest for health is the Grand Est incubator dedicated to healthcare start-ups at the European level. Born from the initiative of the Quest for change incubator network (located in Reims, Strasbourg, Metz, Charleville-Mézières, Epinal and Mulhouse), the incubator supports more than sixty biotech, medtech and e-health start-ups. Quest for health is positioned as the leading national player in this field. Among the supported start-ups, 21 are winners of the national i-Lab competition (including four grand prizes), five of the i-Nov competition and two … Type: | 42 | 11 | 40 | 7 |
 | Groupe Stratos Groupe STRATOS is an entrepreneurs community providing companies with custom-made solutions. Groupe STRATOS is an entrepreneurs community providing companies with custom-made solutions. Our community is composed of entrepreneurs with expertise on a specific topic and each single member is/was an entrepreneur. Groupe STRATOS was founded in 2020 with the merger of 2 other companies created 10 & 20 years ago. About our advisory activiy : - Fund raisings through our network of +1 000 investors (France & International) - Mergers & Acquisitions - Financial audits (M&A, valuation of companies, due diligence...) - Financial analysis - Strategy & business development - … Type: | 58 | 2 | 58 | 7 |
 | France Deeptech [Automatic translation follows] When science undertakes The community that brings together deeptech players for an entrepreneurial, collective and scientific response to our contemporary challenges Type: | 51 | 16 | 45 | 4 |
 | IMS (Institut du Médicament de Strasbourg) [Automatic translation follows] Interdisciplinary Thematic Institute of the University of Strasbourg The Strasbourg Institute of Medicines meets the challenges of the medicine sector: producing cutting-edge research up to the pre-clinical stage, promoting technological innovation through the creation of start-ups and training the new generation of researchers in the management of medicine innovation. Type: | 17 | 2 | 8 | 7 |
 | HealthTech For Care An endowment fund to support and promote access to care for all patients as well as new medical and drug technologies. The HealthTech For Care endowment fund has three essential missions: - fostering the growth and development of the entire health ecosystem, - advocating for the advancement of innovative therapies and treatments to benefit patients, - promoting enhanced access to care for patients within the European healthcare ecosystem. Health Type: | 27 | 7 | 24 | 8 |
 | Private Equity Magazine [Automatic translation follows] The monthly publication for private equity professionals Find the latest news for private equity professionals on our website and magazine. Deals, surveys and analyses, with a cumulative audience of over 30,000 readers, Private Equity Magazine has become the reference publication for French and European private equity players for 10 years. Type: | 79 | 15 | 76 | 8 |
 | Index Ventures Index helps the most ambitious entrepreneurs turn bold ideas into global businesses. Index Ventures partners with exceptional entrepreneurs – those with unique insight who are intrinsically driven to make their vision a reality. We help them turn their bold ideas into global businesses, and through the companies they build, have a long-lasting and positive impact on the world around us. Index-backed businesses are supported by an experienced team of investors, strategists, and an extensive global network built over three decades of startup investing. Working side-by-side through the scale up journey, we forge deep and long-lasting relationships with founders and their … | 16 | 10 | 4 | 113 |
 | Form the Future CIC We help young people find their route through education into employment, and provide employers access to future talent We connect young people to a world of career possibilities, inspire them to dream big and empower them to fulfil their potential. We want to equip young people with the experience and skills they will need to succeed in their career of choice, and enable businesses to recruit skilled workers locally. We bridge the gap between these two worlds and help them work together and achieve more. We deliver the skills service for the Greater Cambridge Partnership, linking schools and businesses to … Type: | 11 | 2 | 8 | 36 |
 | Tigem Telethon Institute of Genetics and Medicine TIGEM is a multidisciplinary research Institute devoted to the study of the mechanisms underlying rare genetic diseases and to the development of new therapies. The institute is one of the most important centers for fundamental life science research in Italy (https://www.tigem.it/). It is particularly renowned for its research on diseases such as lysosomal disorders, membrane trafficking defects, disorders of liver metabolism, and eye diseases. The unique funding environment of TIGEM forges important critical mass and facilitates opportunities to conduct both long-term and high-impact science that would otherwise be difficult to undertake. TIGEM is a … Type: | 1 | 1 | 1 | 307 |
 | Nature Portfolio Springer Nature publishes journals, databases and online products and services across the life, physical and applied sciences and, most recently, clinical medicine. Content encompasses daily news from award-winning journalists, expert opinion and practical methodology, and more high impact research and reviews than any science publisher. Over 70 journals are published, some in association with prestigious academic societies. Nature Portfolio provides news content through Nature News. Scientific career information and free job postings are offered on Naturejobs. Nature was first published in 1869. Springer Nature has its principal offices in London, New York and Tokyo with offices in offices in Basingstoke, … Type: | 53 | 32 | 9 | 764 |
 | NHS The NHS was launched in 1948. It was born out of a long-held ideal that good healthcare should be available to all, regardless of wealth – one of the NHS's core principles. With the exception of some charges, such as prescriptions, optical services and dental services, the NHS in England remains free at the point of use for all UK residents. This currently stands at more than 64.6 million people in the UK and 54.3 million people in England alone. The NHS in England deals with over 1 million patients every 36 hours. It covers everything, including antenatal screening, routine … Type: | 21 | 6 | 3 | 226,386 |
 | Les Echos [Automatic translation follows] Find on LesEchos.fr all the economic and financial news in France and around the world, discover exclusive analyses, special reports, analyses, columns and large formats. http://www.lesechos.fr/ Type: | 404 | 267 | 152 | 1 |
 | Palais de Tokyo [Automatic translation follows] Contemporary art center, Paris📍 With its 22,000 m2, the Palais de Tokyo stands out with its energy as one of the largest contemporary art centers in Europe. It encourages contemporary creation with an eclectic and inventive program around emerging and established artists from all backgrounds. contemporary art, exhibitions, performances, and concerts Type: | 13 | 7 | 7 | 164 |
 | Rothschild & Co We offer a distinct perspective that makes a meaningful difference to our clients' business and wealth. Rothschild & Co is one of the world's largest independent financial advisory groups. We offer a distinct perspective that makes a meaningful difference to our clients’ business and wealth. With a team of 4,200 talented financial services specialists on the ground in more than 40 countries across the world, we provide independent advice on M&A, strategy and financing, as well as investment and wealth management solutions to large institutions, families, individuals and governments. As a family-controlled business that has been at the centre of … Type: | 28 | 20 | 7 | 5,555 |
 | Insempra We are a biology-powered company enabling businesses to make superior products with nature Insempra is a biology-powered company enabling businesses to make superior products with nature. We combine bioscience and technology to grow matter for new and better products. For too long, businesses have relied on chemical industrialization processes and petrochemicals, depleting our planet’s limited resources. That’s why we are committed to drive the regenerative revolution to manufacture at scale in collaboration with nature. Led by a hand-picked team of biologists, technologists and entrepreneurs with rebel hearts, Insempra is here to create a new school of thought and collective action. … | 2 | 0 | 2 | 39 |
 | American Chemical Society Improving all people’s lives through the transforming power of chemistry. The American Chemical Society is a congressionally chartered independent membership organization that represents professionals at all degree levels and in all fields of the chemical sciences. With more than 150,000 members, ACS is the world’s largest scientific society and one of the world’s leading sources of authoritative scientific information. A nonprofit organization, ACS is at the forefront of the evolving chemistry enterprise and the premier professional home for chemists, chemical engineers and related professions around the globe. ACS is dynamic and visionary, committed to “Improving all people’s lives through the … Type: | 3 | 2 | 0 | 2,284 |
 | GAE Conseil [Automatic translation follows] Expert in the prevention of addictive practices in professional environments: advice, awareness, training, etc. G.A.E Conseil, the leading player in the prevention of addictive practices at work. Founded in 2014, GAE Conseil is an independent consulting firm specializing in the prevention of addictive practices in professional environments (psychoactive products and behavioral addictions). Around the firm's partners and the managers of the various centers of expertise (Audit and Consulting Center, Training Center, Center for Assistance to Employees in Difficulty), the GAE Conseil teams support private and public companies of all sizes and from all sectors of activity in … Type: | 47 | 0 | 46 | 37 |
 | M&M Conseil [Automatic translation follows] Public Affairs - Institutional Relations M&M Conseil has specialized in the organization of institutional events and in public affairs consulting for over 25 years. Working closely with French and European institutions, we organize key meetings between public, private and institutional stakeholders. Public Affairs Consulting, Institutional Communication, Events, and Public Relations Type: | 90 | 6 | 87 | 10 |
 | Novozymes Novozymes has combined with Chr. Hansen to become Novonesis: linkedin.com/company/novonesis. This global biosolutions company of 10,000 people is transforming how the world produces, consumes and lives. In 30-plus industries, its biosolutions help businesses meet their needs and the needs of our planet. Novozymes was formed in 2000 when Novo Nordisk split into three companies: Novo Nordisk A/S, Novozymes A/S and Novo A/S. Novozymes was the world leader in biological solutions with a commitment to Rethink Tomorrow. It served 130 markets with enzymatic, microbial and advanced protein solutions. The company’s solutions enabled higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel … Type: | 13 | 2 | 12 | 4,087 |
 | Material Innovation Initiative Cultivating a global market for next-gen materials across the fashion, automotive, and home goods industries. The Material Innovation Initiative (MII) is a think tank focused on research, knowledge-sharing, and fostering connections to fast-track the development of environmentally preferable and animal-free materials. We work to cultivate a global market for next-gen materials across the fashion, automotive, and home goods industries. Subscribe to our newsletter: bit.ly/MIINews Annual Material Innovation Conference, Environmental Data Coalition, State of the Industry Report on Next-Gen Materials, Brand Engagement Report, Consumer Research, Science & Technology Assessment reports Type: | 6 | 0 | 6 | 25 |
 | TAC ECONOMICS An independent European research group providing advisory services on international economic and financial issues TAC ECONOMICS is a French independent leading provider of economic and financial consulting services with a strong expertise on country risk based on AI and data-driven solutions. Our team of experienced economists and data scientists specializes in providing cutting-edge data, models, and analysis to help our clients detect major risks and evaluate investment opportunities. Our commitment to AI and data-driven solutions is rooted in our pioneering work in the early 1990s, where we developed artificial intelligence tools to predict financial crises in emerging economies and prevent … | 7 | 2 | 3 | 13 |
 | Harlay Avocats #tech#startups#corporate#IP/IT#social#employment#tax Harlay Avocats (anciennement Kahn & Associés) est un cabinet d’avocats indépendant qui occupe depuis plus de vingt ans une place privilégiée dans le domaine du conseil aux entreprises de croissance et aux investisseurs dans les secteurs des technologies, de l’Internet, de l’e-commerce, des télécommunications, des sciences de la vie et des énergies renouvelables. La très bonne connaissance de ces secteurs d’activité permet au Cabinet d’être régulièrement sélectionné par les acteurs clés de ces domaines pour les assister lors de leurs opérations en France et à l’international. Le Cabinet conseille également les entreprises d’industries plus traditionnelles : presse et media, … | 5 | 0 | 4 | 38 |
 | Sitryx Harnessing the power of cell metabolism to develop groundbreaking disease-modifying therapies Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism. Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at … Type: | 3 | 2 | 3 | 51 |
 | IRB Barcelona International research centre devoted to offer biomedical solutions for #cancer and other diseases linked to #aging. IRB Barcelona’s research purpose is to address fundamental biological questions in order to provide groundbreaking solutions to unmet medical needs. Our institute is organised around three major research challenges: Cancer Science, Aging and Metabolism, and Mechanisms of Disease, with the aim to decipher why diseases develop and find new ways to diagnose, prevent and treat them. Approximately 400 scientists, technical and administrative staff from 29 countries currently work at IRB Barcelona. IRB Barcelona's ultimate objective is to translate research results to the clinic and … Type: | 3 | 2 | 2 | 478 |
 | SafeHeal Reshaping RecoveryTM Established in 2015 and based in France, SafeHealTM is a clinical stage medical device manufacturer. Specializing in the development of anastomosis protection devices for colorectal surgery, SafeHeal’s premier device, Colovac, was invented by French surgeon Charam Khosrovani to eliminate the need for diverting ostomies in patients undergoing colectomy. medical device Type: | 2 | 1 | 0 | 19 |
Startup